{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:11:23Z","timestamp":1769764283586,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>High-mobility group box 1 (HMGB1) is a late mediator of lethal systemic inflammation. Acute liver failure (ALF) has been shown to trigger systemic inflammation in clinical and animal studies. To evaluate the possibility of HMGB1 cytoplasmic translocation in ALF, we determined whether HMGB1 is released in hepatocytes and end organ in patients with liver failure\/injury.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HepG2 cell were stimulated with LPS or TNF-\u03b1, the increase of HMGB1 extracellularly in the culture medium and intracellularly in various cellular fractions were determined by western blot or immunocytochemistry. To observe sub-cellular location of HMGB1 in hepatocytes, liver specimens were obtained from 6 patients with ALF caused by HBV infection, 10 patients with chronic viral hepatitis B, 6 healthy controls, as well as animals model of ALF by intraperitoneal administration of D-GalN (600 mg\/kg) and LPS (0.5 mg\/kg).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In HepG2 cell culture, LPS or TNF actively induced HMGB1 cytoplasmic translocation and release in a time- and dose-dependent fashion. In animal model of ALF, cytoplasmic HMGB1 translocation was observed in hepatocyts as early as 3 hours post onset of ALF. In patients with ALF caused by HBV infection, cytoplasmic HMGB1 translocation was similarly observed in some hepatocytes of the liver specimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Cytoplasmic HMGB1 translocation may occur during ALF, which may potentially contribute to the pathogenesis of liver inflammatory diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-11-21","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:20:26Z","timestamp":1300303226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["HMGB1 cytoplasmic translocation in patients with acute liver failure"],"prefix":"10.1186","volume":"11","author":[{"given":"Rong-Rong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Shan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Xiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-Hong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Gong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"556_CR1","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1128\/MCB.19.8.5237","volume":"19","author":"M Bustin","year":"1999","unstructured":"Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999, 19: 5237-5246.","journal-title":"Mol Cell Biol"},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanoa vS, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999, 285: 248-251. 10.1126\/science.285.5425.248.","journal-title":"Science"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","volume":"165","author":"E Abraham","year":"2000","unstructured":"Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000, 165: 2950-2954.","journal-title":"J Immunol"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002, 418: 191-195. 10.1038\/nature00858.","journal-title":"Nature"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005, 5: 331-342. 10.1038\/nri1594.","journal-title":"Nat Rev Immunol"},{"key":"556_CR6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.embor.7400759","volume":"7","author":"HE Harris","year":"2006","unstructured":"Harris HE, Raucci A: Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep. 2006, 7: 774-778.","journal-title":"EMBO Rep"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2007","unstructured":"Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007, 81: 1-5. 10.1189\/jlb.0306164.","journal-title":"J Leukoc Biol"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","volume":"101","author":"C Fiuza","year":"2003","unstructured":"Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003, 101: 2652-2660. 10.1182\/blood-2002-05-1300.","journal-title":"Blood"},{"key":"556_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2796.2003.01204.x","volume":"254","author":"CJ Treutiger","year":"2003","unstructured":"Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE: High mobility group 1 B-box mediates activation of human endothelium. J Intern Med. 2003, 254: 375-385. 10.1046\/j.1365-2796.2003.01204.x.","journal-title":"J Intern Med"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000, 192: 565-570. 10.1084\/jem.192.4.565.","journal-title":"J Exp Med"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"R1538","DOI":"10.1152\/ajpregu.00272.2007","volume":"293","author":"RM Levy","year":"2007","unstructured":"Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol. 2007, 293: R1538-1544. 10.1152\/ajpregu.00272.2007.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","volume":"33","author":"J Sunden-Cullberg","year":"2005","unstructured":"Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med. 2005, 33: 564-573. 10.1097\/01.CCM.0000155991.88802.4D.","journal-title":"Crit Care Med"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00134-007-0691-2","volume":"33","author":"S Gibot","year":"2007","unstructured":"Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med. 2007, 33: 1347-1353. 10.1007\/s00134-007-0691-2.","journal-title":"Intensive Care Med"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/01.CCM.0000259534.68873.2A","volume":"35","author":"DC Angus","year":"2007","unstructured":"Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L: Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med. 2007, 35: 1061-1067. 10.1097\/01.CCM.0000259534.68873.2A.","journal-title":"Crit Care Med"},{"key":"556_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.mpa.0000236741.15477.8b","volume":"33","author":"T Yasuda","year":"2006","unstructured":"Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y: Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 2006, 33: 359-363. 10.1097\/01.mpa.0000236741.15477.8b.","journal-title":"Pancreas"},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.shk.0000209540.99176.72","volume":"25","author":"RS Goldstein","year":"2006","unstructured":"Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ: Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 2006, 25: 571-574. 10.1097\/01.shk.0000209540.99176.72.","journal-title":"Shock"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.20703","volume":"41","author":"J Polson","year":"2005","unstructured":"Polson J, Lee WM: AASLD position paper: the management of acute liver failure. Hepatology. 2005, 41: 1179-1197. 10.1002\/hep.20703.","journal-title":"Hepatology"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ: Hepatitis B: the virus and disease. Hepatology. 2009, 49: S13-21. 10.1002\/hep.22881.","journal-title":"Hepatology"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1055\/s-2008-1073114","volume":"28","author":"WM Lee","year":"2008","unstructured":"Lee WM: Etiologies of acute liver failure. Semin Liver Dis. 2008, 28: 142-152. 10.1055\/s-2008-1073114.","journal-title":"Semin Liver Dis"},{"key":"556_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/jhep.2000.17687","volume":"32","author":"N Rolando","year":"2000","unstructured":"Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R: The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000, 32: 734-739. 10.1053\/jhep.2000.17687.","journal-title":"Hepatology"},{"key":"556_CR21","first-page":"1428","volume":"147","author":"MA Boermeester","year":"1995","unstructured":"Boermeester MA, Houdijk AP, Meyer S, Cuesta MA, Appelmelk BJ, Wesdorp RI, Hack CE, Van Leeuwen PA: Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal\/permeability-increasing protein. Am J Pathol. 1995, 147: 1428-1440.","journal-title":"Am J Pathol"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(88)90006-2","volume":"2","author":"Y Muto","year":"1988","unstructured":"Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R: Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 1988, 2: 72-74. 10.1016\/S0140-6736(88)90006-2.","journal-title":"Lancet"},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1478-3231.2010.02262.x","volume":"30","author":"Z Wu","year":"2010","unstructured":"Wu Z, Han M, Chen T, Yan W, Ning Q: Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010, 30: 782-794. 10.1111\/j.1478-3231.2010.02262.x.","journal-title":"Liver Int"},{"key":"556_CR24","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.4049\/jimmunol.180.4.2531","volume":"180","author":"Y Sha","year":"2008","unstructured":"Sha Y, Zmijewski J, Xu Z, Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol. 2008, 180: 2531-2537.","journal-title":"J Immunol"},{"key":"556_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1084\/jem.178.5.1541","volume":"178","author":"K Ando","year":"1993","unstructured":"Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV: Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 1993, 178: 1541-1554. 10.1084\/jem.178.5.1541.","journal-title":"J Exp Med"},{"key":"556_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1053\/gast.2000.9364","volume":"119","author":"K Streetz","year":"2000","unstructured":"Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, Brenner D, Manns M, Trautwein C: Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology. 2000, 119: 446-460. 10.1053\/gast.2000.9364.","journal-title":"Gastroenterology"},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1189\/jlb.0306173","volume":"81","author":"G Sitia","year":"2007","unstructured":"Sitia G, Iannacone M, Muller S, Bianchi ME, Guidotti LG: Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol. 2007, 81: 100-107. 10.1189\/jlb.0306173.","journal-title":"J Leukoc Biol"},{"key":"556_CR28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/iai.64.3.734-738.1996","volume":"64","author":"A Morikawa","year":"1996","unstructured":"Morikawa A, Sugiyama T, Kato Y, Koide N, Jiang GZ, Takahashi K, Tamada Y, Yokochi T: Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect Immun. 1996, 64: 734-738.","journal-title":"Infect Immun"},{"key":"556_CR29","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.2353\/ajpath.2007.061056","volume":"170","author":"MK Le","year":"2007","unstructured":"Le MK, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B: Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol. 2007, 170: 1954-1963. 10.2353\/ajpath.2007.061056.","journal-title":"Am J Pathol"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-230X-9-99","volume":"9","author":"B Feng","year":"2009","unstructured":"Feng B, Wu SM, Lv S, Liu F, Chen HS, Gao Y, Dong FT, Wei L: A novel scoring system for prognostic prediction in d-galactosamine\/lipopolysaccharide-induced fulminant hepatic failure BALB\/c mice. BMC Gastroenterol. 2009, 9: 99-10.1186\/1471-230X-9-99.","journal-title":"BMC Gastroenterol"},{"key":"556_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/path.1298","volume":"199","author":"L Leifeld","year":"2003","unstructured":"Leifeld L, Dumoulin FL, Purr I, Janberg K, Trautwein C, Wolff M, Manns MP, Sauerbruch T, Spengler U: Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol. 2003, 199: 335-344. 10.1002\/path.1298.","journal-title":"J Pathol"},{"key":"556_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0039-6060(99)70182-0","volume":"126","author":"H Wang","year":"1999","unstructured":"Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A, Tracey KJ: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery. 1999, 126: 389-392. 10.1016\/S0039-6060(99)70182-0.","journal-title":"Surgery"},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"C990","DOI":"10.1152\/ajpcell.00308.2005","volume":"290","author":"S Liu","year":"2006","unstructured":"Liu S, Stolz DB, Sappington PL, Macias CA, Killeen ME, Tenhunen JJ, Delude RL, Fink MP: HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol. 2006, 290: C990-999. 10.1152\/ajpcell.00308.2005.","journal-title":"Am J Physiol Cell Physiol"},{"key":"556_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SHK.0b013e3181df0433","volume":"34","author":"K Takano","year":"2010","unstructured":"Takano K, Shinoda M, Tanabe M, Miyasho T, Yamada S, Ono S, Masugi Y, Suda K, Fukunaga K, Hayashida T, Hibi T, Obara H, Takeuchi H, Kawachi S, Kawasako K, Okamoto M, Yokota H, Maruyama I, Kitagawa Y: Protective Effect of High-Mobility Group Box 1 Blockade on Acute Liver Failure in Rats. Shock. 2010, 34: 573-579. 10.1097\/SHK.0b013e3181df0433.","journal-title":"Shock"},{"key":"556_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-2008-1073117","volume":"28","author":"RJ Fontana","year":"2008","unstructured":"Fontana RJ: Acute liver failure due to drugs. Semin Liver Dis. 2008, 28: 175-187. 10.1055\/s-2008-1073117.","journal-title":"Semin Liver Dis"},{"key":"556_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/1566524033479555","volume":"3","author":"XM Yin","year":"2003","unstructured":"Yin XM, Ding WX: Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr Mol Med. 2003, 3: 491-508. 10.2174\/1566524033479555.","journal-title":"Curr Mol Med"},{"key":"556_CR37","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/hep.22214","volume":"47","author":"T Torisu","year":"2008","unstructured":"Torisu T, Nakaya M, Watanabe S, Hashimoto M, Yoshida H, Chinen T, Yoshida R, Okamoto F, Hanada T, Torisu K, Takaesu G, Kobayashi T, Yasukawa H, Yoshimura A: Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology. 2008, 47: 1644-1654. 10.1002\/hep.22214.","journal-title":"Hepatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-11-21\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:08:28Z","timestamp":1630501708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-11-21","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]},"assertion":[{"value":"19 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}